SUNNYLIFE PHARMA INC.
Biotech · Private
Small molecule inhibitors of HPV E6 protein that restore p53 function to block viral replication and prevent cervical cancer progression
sunnylifepharma.com →- Grants
- $550K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 1 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Structure-activity relationship of small molecule inhibitors of human papillomavirus E6 protein will be tested. | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Structure activity relationship of small molecule inhibitors of human papillomavirus E protein will be tested | $275,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Structure-activity relationship of small molecule inhibitors of human papillomavirus E6 protein will be tested. | $50,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1892 | D2G ONCOLOGY, INC. | — | $6.6M |
| 1893 | OCATA THERAPEUTICS, INC. | — | — |
| 1894 | CELLECTAR, Inc. | — | $2.7M |
| 1895 | SUNNYLIFE PHARMA INC. | — | — |
| 1896 | NASH HOLDINGS, LLC | — | $1.4M |
| 1897 | Cybele Microbiome Inc | — | $1.6M |
| 1898 | Direct Biologics, LLC | — | $12M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Tetrahydro-azepinoquinolines As Agonists Of The 5-HT2C Receptorgranted
- Tetrahydro-azepinoquinolines As Agonists Of The 5-HT2C Receptorapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.